Short Interest in P3 Health Partners Inc. (NASDAQ:PIII) Decreases By 19.8%

P3 Health Partners Inc. (NASDAQ:PIII) was the recipient of a significant drop in short interest during the month of November. As of November 30th, there was short interest totalling 818,000 shares, a drop of 19.8% from the November 15th total of 1,020,000 shares. Based on an average trading volume of 739,600 shares, the days-to-cover ratio is presently 1.1 days. Approximately 0.9% of the shares of the company are short sold.

Institutional Inflows and Outflows

Several large investors have recently bought and sold shares of PIII. Emfo LLC raised its position in shares of P3 Health Partners by 39.8% during the second quarter. Emfo LLC now owns 1,427,689 shares of the company’s stock worth $643,000 after acquiring an additional 406,418 shares during the last quarter. Renaissance Technologies LLC increased its holdings in P3 Health Partners by 188.1% in the second quarter. Renaissance Technologies LLC now owns 111,800 shares of the company’s stock worth $50,000 after purchasing an additional 73,000 shares in the last quarter. Armistice Capital LLC bought a new position in shares of P3 Health Partners during the 2nd quarter worth approximately $3,557,000. Finally, Geode Capital Management LLC grew its position in shares of P3 Health Partners by 115.2% during the 3rd quarter. Geode Capital Management LLC now owns 1,029,259 shares of the company’s stock worth $398,000 after buying an additional 550,925 shares during the period. 7.75% of the stock is owned by institutional investors.

P3 Health Partners Trading Down 4.1 %

Shares of PIII stock traded down $0.01 during mid-day trading on Friday, reaching $0.21. 388,541 shares of the stock traded hands, compared to its average volume of 469,751. P3 Health Partners has a 1-year low of $0.19 and a 1-year high of $1.78. The company has a quick ratio of 0.53, a current ratio of 0.53 and a debt-to-equity ratio of 1.11. The company has a market cap of $73.56 million, a price-to-earnings ratio of -0.24 and a beta of 0.98. The stock’s fifty day simple moving average is $0.31 and its two-hundred day simple moving average is $0.45.

Analyst Upgrades and Downgrades

Separately, TD Cowen reduced their target price on P3 Health Partners from $0.90 to $0.25 and set a “hold” rating for the company in a research note on Wednesday, November 20th.

About P3 Health Partners

P3 Health Partners Inc, a patient-centered and physician-led population health management company, provides superior care services in the United States. It operates clinics and wellness centers. P3 Health Partners Inc was founded in 2020 and is based in Henderson, Nevada.